ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

ORI Must Release Documents In Fisher Case, Judge Rules

September 8, 1995

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

Space Station Attacked By Health Research Advocates on Earth

May 8, 1992

Las Vegas Cancer Center Cuts Staff, Seeks Lifelines During “Perfect Storm”

May 20, 2011